CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

American Regent, Inc. recalls Epinephrine Injection

Read the official FDA notice

Published
16 Sept 2026
Units affected
31,935 30mL-vials
Agency
FDA
Country
United States

The hazard

Presence of Particulate Matter and Lack of Assurance of Sterility. Particulate matter identified as nylon, cellulosic, acrylic, polyethylene and glass and broken and leaking vials.

Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Epinephrine Injection, USP, 30 mg/30 mL (1mg/mL), 30 mL-Multiple-Dose Vial, Rx Only, For Intravenous Infusion, intramuscular and Subcutaneous Use, AMERICAN REGENT INC., SHIRLEY, NY 11967. NDC 0517-3030-01

Brand / company
American Regent, Inc.
Codes / lots
Lots: 25128L1C0, Exp. August 31, 2026; 25280L1C0, Exp. October 31, 2026; 26108L1C0, Exp. July 31, 2027
Distribution
Nationwide within the U.S.A
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 16 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.